Ulcerative Colitis Studies

BVL Research has multiple studies currently enrolling in Ulcerative Colitis including:

• Abivax ABX 464-106

• Sanofi DRI16804

• Roche GA45329-Ametrine-1

• Merck 7240-001 & 7240-011-Coming Soon!

• Takeda 4054-Vedolizumab

You, or someone you know, may be able to take part if you/they:

·         are 18–75 years of age

·         have been diagnosed with UC or CD for at least 3 months

·         have tried at least 1 medication that did not work, stopped working, or caused too many side effects.

For more information Contact Us.